Bristol Myers (Brazil) Today
| BMYB34 Stock | BRL 338.87 1.48 0.44% |
Performance17 of 100
| Odds Of DistressLess than 9
|
Bristol Myers is trading at 338.87 as of the 22nd of November 2024, a 0.44% up since the beginning of the trading day. The stock's open price was 337.39. Bristol Myers has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Bristol Myers Squibb are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of December 2022 and ending today, the 22nd of November 2024. Click here to learn more.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOLMYERSDRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. The company has 2.13 B outstanding shares. More on Bristol Myers Squibb
Moving together with Bristol Stock
Moving against Bristol Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bristol Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bristol Myers' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bristol Myers or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President | Ann Judge |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Bristol Myers Squibb (BMYB34) is traded on Sao Paulo Exchange in Brazil and employs 41 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 812.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bristol Myers Squibb operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 2.13 B outstanding shares.
Bristol Myers Squibb has accumulated about 29.36 B in cash with 16.21 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.95.
Check Bristol Myers Probability Of Bankruptcy
Bristol Myers Squibb Risk Profiles
Although Bristol Myers' alpha and beta are two of the key measurements used to evaluate Bristol Myers' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.03 | |||
| Semi Deviation | 0.6805 | |||
| Standard Deviation | 1.94 | |||
| Variance | 3.76 |
Bristol Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bristol Myers without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Bristol Myers Corporate Management
Elected by the shareholders, the Bristol Myers' board of directors comprises two types of representatives: Bristol Myers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bristol. The board's role is to monitor Bristol Myers' management team and ensure that shareholders' interests are well served. Bristol Myers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bristol Myers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jitendra Tyagi | Head India | Profile | |
| Cari Gallman | VP Officer | Profile | |
| David Elkins | Ex CFO | Profile | |
| BCH BM | Ex Devel | Profile | |
| Giovanni MD | Chairman CEO | Profile | |
| Greg Meyers | Ex Officer | Profile |
Additional Information and Resources on Investing in Bristol Stock
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the CEOs Directory module to screen CEOs from public companies around the world.